BE678537A - - Google Patents
Info
- Publication number
- BE678537A BE678537A BE678537DA BE678537A BE 678537 A BE678537 A BE 678537A BE 678537D A BE678537D A BE 678537DA BE 678537 A BE678537 A BE 678537A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- amidopyrine
- promethazine
- trimethoxybenzoate
- parts
- Prior art date
Links
- 229960000212 aminophenazone Drugs 0.000 claims description 21
- 229960003910 promethazine Drugs 0.000 claims description 18
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 claims description 17
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- HZNQSWJZTWOTKM-UHFFFAOYSA-N 2,3,4-trimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(OC)=C1OC HZNQSWJZTWOTKM-UHFFFAOYSA-N 0.000 claims description 12
- 230000000202 analgesic effect Effects 0.000 claims description 10
- 230000001754 anti-pyretic effect Effects 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- RAFOHKSPUDGZPR-VOTSOKGWSA-N vinbarbital Chemical compound CC\C=C(/C)C1(CC)C(=O)NC(=O)NC1=O RAFOHKSPUDGZPR-VOTSOKGWSA-N 0.000 claims description 4
- 229960001167 vinbarbital Drugs 0.000 claims description 4
- 239000002221 antipyretic Substances 0.000 claims description 3
- 239000003326 hypnotic agent Substances 0.000 claims description 2
- 230000000147 hypnotic effect Effects 0.000 claims description 2
- UOELMDIOCSFSEN-FVZZCGLESA-N 7-Dehydrositosterol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)C=C[C@H](C)C(C)C)=CC=C1C[C@@H](O)CCC1=C.C1[C@@H](O)CCC2(C)C(CC[C@@]3([C@@H]([C@H](C)C=C[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 UOELMDIOCSFSEN-FVZZCGLESA-N 0.000 claims 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- IXRNQIKIVWWFBH-UHFFFAOYSA-N n-(1-phenylethenyl)acetamide Chemical compound CC(=O)NC(=C)C1=CC=CC=C1 IXRNQIKIVWWFBH-UHFFFAOYSA-N 0.000 claims 1
- 208000002193 Pain Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 7
- 239000000829 suppository Substances 0.000 description 7
- 239000003826 tablet Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000036592 analgesia Effects 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 3
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229960000632 dexamfetamine Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229940008238 amphetamine sulfate Drugs 0.000 description 1
- PYHRZPFZZDCOPH-UHFFFAOYSA-N amphetamine sulfate Chemical compound OS(O)(=O)=O.CC(N)CC1=CC=CC=C1.CC(N)CC1=CC=CC=C1 PYHRZPFZZDCOPH-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR12658A FR4310M (enrdf_load_html_response) | 1965-04-09 | 1965-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE678537A true BE678537A (enrdf_load_html_response) | 1966-09-01 |
Family
ID=8576074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE678537D BE678537A (enrdf_load_html_response) | 1965-04-09 | 1966-03-28 |
Country Status (2)
| Country | Link |
|---|---|
| BE (1) | BE678537A (enrdf_load_html_response) |
| FR (1) | FR4310M (enrdf_load_html_response) |
-
1965
- 1965-04-09 FR FR12658A patent/FR4310M/fr not_active Expired
-
1966
- 1966-03-28 BE BE678537D patent/BE678537A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR4310M (enrdf_load_html_response) | 1966-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vane et al. | Mechanism of action of nonsteroidal anti-inflammatory drugs | |
| WO2021074284A1 (fr) | Utilisation de nictotinamide mononucléotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoïde et compositions correspondantes | |
| JP2005533830A5 (enrdf_load_html_response) | ||
| US4880742A (en) | Prostaglandin biosynthesis inhibitors | |
| EP2146714B1 (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson | |
| BE678537A (enrdf_load_html_response) | ||
| EP0402208B1 (fr) | Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique | |
| CA2684171C (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens | |
| LU85242A1 (fr) | Nouvelle association medicamenteuse | |
| CA2122780C (fr) | Utilisation de la selegiline en medecine veterinaire | |
| CA1027866A (en) | Vincamin and theophyllin based drug and therapeutic use thereof | |
| RU2802833C1 (ru) | Применение кверцетина в качестве диуретического, салуретического и креатининуретического средства | |
| RU2802874C1 (ru) | Применение дигидрокверцетина в качестве диуретического, салуретического и креатининуретического средства | |
| RU94027770A (ru) | Препарат для профилактики и лечения гинекологических и послеродовых заболеваний самок сельскохозяйственных животных и способ его применения | |
| RU2228742C2 (ru) | Способ лечения рецидивирующего иридоциклохориоидита лошадей | |
| RU2679447C1 (ru) | Применение L-лизина тиазотата как активной основы лекарственных средств гепатопротекторного и детоксикационного действия | |
| RU2228741C2 (ru) | Способ лечения рецидивирующего иридоциклохориоидита лошадей | |
| JPH0251405B2 (enrdf_load_html_response) | ||
| EP3725312A1 (en) | New chemical compound containing active enantiomer s-(-) ketorolac tromethamine for the treatment of pain | |
| US20030191188A1 (en) | Method for treating migraine symptoms with ibuprofen and salts thereof | |
| JP2017095401A (ja) | 医薬組成物 | |
| CN115778944A (zh) | 蛇床子素在制备改善或治疗认知功能障碍的药物中的用途 | |
| WO2024171073A1 (en) | Compositions comprising 3,4-methylenedioxymethamphetamine, optionally in combination with n-acylethanolamines, and uses thereof | |
| WO2024221023A1 (en) | Anti-inflammatory, analgesic and antipyretic suppository | |
| KR20160002499A (ko) | 안전성 및 효능이 증가된 월경통 완화 또는 치료용 복합제 조성물 |